Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma

BACKGROUND: Robust imaging biomarkers are needed for risk stratification in stage I lung adenocarcinoma patients in order to select optimal treatment regimen. We aimed to construct and validate a radiomics nomogram for predicting the disease-free survival (DFS) of patients with resected stage I lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Dong, Wang, Ting-Ting, Huang, Shu-Jung, Deng, Jia-Jun, Ren, Yi-Jiu, Yang, Yang, Wu, Jun-Qi, Zhang, Lei, Fei, Ke, Sun, Xi-Wen, She, Yun-Lang, Chen, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481634/
https://www.ncbi.nlm.nih.gov/pubmed/32953490
http://dx.doi.org/10.21037/tlcr-19-577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481634/
https://www.ncbi.nlm.nih.gov/pubmed/32953490
http://dx.doi.org/10.21037/tlcr-19-577

Ejemplares similares